OmniAb (OABI) Current Leases (2021 - 2026)
OmniAb (OABI) reported Current Leases of $3.9 million for Q1 2026, up 3.33% year-over-year from $3.8 million in Q1 2025, and up 1.57% on a QoQ basis from $3.9 million in Q4 2025.
OmniAb (OABI) has 6 years of Current Leases data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Current Leases rose 3.33% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 3.33% YoY) and the FY2025 annual result came in at $3.9 million, up 2.56% from the prior year.
- Current Leases climbed to $3.9 million in Q1 2026 per OABI's latest filing, from $3.9 million in the prior quarter.
- Across five years, Current Leases topped out at $3.9 million in Q1 2026 and bottomed at $1.8 million in Q4 2022.
- The 5-year median for Current Leases is $3.7 million (2024), against an average of $3.5 million.
- The widest annual swing landed in 2022, when Current Leases soared 207.96%; it then advanced 2.56% in 2025.
- Tracing OABI's Current Leases over 5 years: stood at $1.8 million in 2022, then surged by 95.84% to $3.5 million in 2023, then climbed by 8.49% to $3.8 million in 2024, then grew by 2.56% to $3.9 million in 2025, then gained by 1.57% to $3.9 million in 2026.
- Per Business Quant, the three latest OABI Current Leases figures stand at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.88 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 578,000.00 |